MicroRNAs in Diseases and Disorders : Emerging Therapeutic Targets

個数：

MicroRNAs in Diseases and Disorders : Emerging Therapeutic Targets

Peplow, Philip V (EDT)/ Martinez, Bridget (EDT)/ Calin, George A (EDT)

ウェブストア価格 ¥52,448（本体¥47,680）
Royal Society of Chemistry（2019/05発売）
外貨定価 US$ 250.00
ポイント 476pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 504 p.
言語 ENG
商品コード 9781788013949
DDC分類 572

Full Description

From pathology to treatment, MicroRNAs in Diseases and Disorders highlights the role of microRNAs (miRNAs) in the development and progression of a variety of diseases, including cancer, neurological disease, endocrine disease and autoimmune disease, and underscores the utilization of miRNA targets in the treatment of these conditions. Providing a comprehensive account, this book also includes the identification of miRNAs as diagnostic and prognostic biomarkers for disease, as well as evaluates translational value from clinical trials using synthesized and functionalized miRNA mimics and inhibitors.
With a global contribution list and chapters from leading experts across the field, MicroRNAs in Diseases and Disorders is an invaluable reference to miRNA researchers and health professionals in a variety of disease areas in government, academia and industry. The book will also appeal to pharmaceutical and medicinal chemists with an interest in miRNA targeting therapeutics, as well as to advanced students in chemical biology and drug discovery.

Role of Nutrition, the Epigenome, and MicroRNAs in Cancer Pathogenesis;

Role of MicroRNAs in Metabolic Diseases;

Circulating MicroRNAs as Biomarkers of Coeliac Disease and Other Intestinal Pediatric Diseases - Experimental and Bioinformatics Challenges from the Bench to the Bedside;

MicroRNAs and Mycobacterial Infections in Humans and Domestic Animals;

Regulation and Function of MicroRNAs in Kidney Diseases;

Involvement of MicroRNAs in Autoimmune Diseases;

MicroRNAs in Ischemic Stroke, Hemorrhagic Stroke, and Traumatic Brain Injury;

MicroRNAs as Biomarkers for Neurological Disorders;

MicroRNAs in Endocrine Disorders;

MicroRNAs in Skin Development, Function and Disorders;

MicroRNAs in Haematological Diseases;

Discovery and Therapeutic Relevance of Small Molecule Modifiers of MicroRNA Function;

MicroRNA-specific Argonaute 2 Protein Inhibitors and AGO Loading Inhibitors;

Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics;

Modification of Drug Response in Cancer by MicroRNAs;

Nanoparticle Delivery of MiRNA in Cancer